Clinical Trial To Evaluate ANT-1207 In Subjects With Crow's Feet

PHASE2CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

May 31, 2012

Conditions
Lateral Canthal LinesCrow's Feet
Interventions
BIOLOGICAL

ANT-1207

The interventions differ by dose of investigational product applied.

BIOLOGICAL

Botulinum Toxin, Type A

The interventions differ by dose of investigational product applied.

BIOLOGICAL

Botulinum Toxin Type A

The interventions differ by dose of investigational product applied.

Trial Locations (6)

10010

Gramercy Park Dermatology, New York

27519

Cary Skin Care, Cary

33140

Baumann Cosmetic & Research Institute, Miami Beach

33401

Palm Beach Esthetic Dermatology and Laser Center, West Palm Beach

35205

Total Skin & Beauty Dermatology Center, Birmingham

70006

William Coleman III, MD, APMC, Metairie

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Anterios Inc.

INDUSTRY

NCT01358695 - Clinical Trial To Evaluate ANT-1207 In Subjects With Crow's Feet | Biotech Hunter | Biotech Hunter